Article

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

2020-03-14

Abstract excerpt

<h4>ABSTRACT</h4> The outbreak of the coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has infected more than 100,000 people worldwide with over 3,000 deaths since December 2019. There is no cure for COVID-19 and the vaccine development is estimated to require 12-18 months. Here we demonstrate a CRISPR-Cas13-based strategy, PAC-MAN ( P rophylactic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d2911160-2d48-54aa-b02f-8b606e61f86b
DOI: 10.1101/2020.03.13.991307

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenzaDOI 10.1101/2020.03.13.991307Read

A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA virusesSemantic proximity Read

CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and TherapeuticsSemantic proximity Read

CRISPR/Cas13: A potential therapeutic option of COVID-19Semantic proximity Read

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to TherapeuticsSemantic proximity Read

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaSemantic proximity Read

Progress in CRISPR Technology for Antiviral Treatments: Genome Editing as a Potential Cure for Chronic Viral InfectionsSemantic proximity Read

Novel miniature CRISPR–Cas13 systems from uncultivated microbes effective in degrading SARS-CoV-2 sequences and influenza virusesSemantic proximity Read

Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applicationsSemantic proximity Read

Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsSemantic proximity Read

Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronavirusesSemantic proximity Read

CRISPR/Cas9 gene editing technology and its application to the coronavirus disease (COVID-19), a reviewSemantic proximity Read

Genome-scale CRISPR Screens Identify Host Factors that Promote Human Coronavirus InfectionSemantic proximity Read